Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Bausch and Lomb
Bausch and Lomb
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Valeant Pharmaceuticals to acquire Synergetics USA
Acquisition will further enhance Bausch + Lomb's presence around the world in the rapidly evolving field of vitreoretinal surgery
Finance
Valeant to purchase Bausch + Lomb for US$8.7bn
Will establish Valeant as a global leader in eye health and dermatology
Finance
Bausch + Lomb to purchase ISTA Pharmaceuticals for US$500m
Adds anti-inflammatory, allergy and glaucoma products to portfolio
Finance
Bausch + Lomb launches pharmaceuticals business in India
Partnership with Micro Labs will provide high quality manufacturing capabilities
Finance
Bausch + Lomb names global president, pharmaceuticals
Daniel Wechsler joins from Merck & Co
Research & Development
Bausch + Lomb wins rights to NCX 116
Worldwide rights for the NCX 116 compound have been granted to Bausch + Lomb for the treatment of glaucoma and ocular hypertension.
Media
Bausch & Lomb sets up global pharma hq in New Jersey
<p>Bausch & Lomb is to open its global pharmaceutical headquarters in Madison, US on Monday, 20 July.</p>
Subscribe now